We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$1.62B
AUM Growth
+$208M
Cap. Flow
+$56.5M
Cap. Flow %
3.49%
Top 10 Hldgs %
23.27%
Holding
546
New
32
Increased
378
Reduced
121
Closed
11

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$3.98M
2
AMZN icon
Amazon
AMZN
+$3.04M
3
TSLA icon
Tesla
TSLA
+$2.66M
4
UNP icon
Union Pacific
UNP
+$2.66M
5
AAPL icon
Apple
AAPL
+$2.55M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.38M
2
CL icon
Colgate-Palmolive
CL
+$2.12M
3
MDT icon
Medtronic
MDT
+$1.61M
4
MRNA icon
Moderna
MRNA
+$1.56M
5
GNRC icon
Generac Holdings
GNRC
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 15.39%
3 Financials 11.91%
4 Consumer Discretionary 10.39%
5 Communication Services 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOV icon
226
Dover
DOV
$28.1B
$1.33M 0.08%
7,308
+68
+0.9% +$11.5K
CE icon
227
Celanese
CE
$4.92B
$1.32M 0.08%
7,862
+159
+2% +$25.9K
BIO icon
228
Bio-Rad Laboratories Class A
BIO
$9.53B
$1.31M 0.08%
1,736
+26
+2% +$19.5K
TROW icon
229
T. Rowe Price
TROW
$24.3B
$1.3M 0.08%
6,637
-2
-0% -$406
ADM icon
230
Archer Daniels Midland
ADM
$38.8B
$1.3M 0.08%
19,254
-355
-2% -$22.9K
ILMN icon
231
Illumina
ILMN
$29.1B
$1.3M 0.08%
3,517
+177
+5% +$67.1K
HPQ icon
232
HP
HPQ
$26.6B
$1.29M 0.08%
34,306
-1,897
-5% -$62K
SYY icon
233
Sysco
SYY
$40.3B
$1.29M 0.08%
16,444
+670
+4% +$51.6K
HZNP
234
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.29M 0.08%
11,930
-2,722
-19% -$297K
EXR icon
235
Extra Space Storage
EXR
$31B
$1.27M 0.08%
5,600
-4,670
-45% -$925K
DOW icon
236
Dow Inc
DOW
$22.6B
$1.24M 0.08%
21,892
+67
+0.3% +$3.82K
LHX icon
237
L3Harris
LHX
$53.3B
$1.24M 0.08%
5,816
-41
-0.7% -$9.09K
FTNT icon
238
Fortinet
FTNT
$119B
$1.24M 0.08%
17,175
+2,475
+17% +$163K
BMRN icon
239
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.23M 0.08%
13,971
+4,800
+52% +$396K
DLR icon
240
Digital Realty Trust
DLR
$70.6B
$1.21M 0.08%
6,852
-1,040
-13% -$167K
SRE icon
241
Sempra
SRE
$55.9B
$1.21M 0.07%
18,216
-40
-0.2% -$2.54K
MPC icon
242
Marathon Petroleum
MPC
$94.5B
$1.2M 0.07%
18,790
-1,827
-9% -$117K
F icon
243
Ford
F
$55.7B
$1.2M 0.07%
57,798
+12,949
+29% +$238K
SNOW icon
244
Snowflake
SNOW
$116B
$1.2M 0.07%
3,536
+490
+16% +$171K
ZBRA icon
245
Zebra Technologies
ZBRA
$18.1B
$1.19M 0.07%
2,003
+61
+3% +$34.6K
SJM icon
246
J.M. Smucker
SJM
$12.5B
$1.17M 0.07%
8,646
+98
+1% +$12.5K
WU icon
247
Western Union
WU
$2.2B
$1.17M 0.07%
65,447
-3,240
-5% -$59.8K
XYZ
248
Block Inc
XYZ
$47.5B
$1.16M 0.07%
7,179
+443
+7% +$96K
COO icon
249
Cooper Companies
COO
$15B
$1.13M 0.07%
10,760
+280
+3% +$28.5K
STZ icon
250
Constellation Brands
STZ
$22.9B
$1.12M 0.07%
4,472
+200
+5% +$45.6K
8 9
10
11 12

Similar funds

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return

Meiji Yasuda Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Meiji Yasuda Asset Management held 546 positions worth $1.62B, up 15% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meiji Yasuda Asset Management deployed $56.5M of net new capital in Q4 2021, opening 32 new positions and adding to 378 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,430 shares worth $548K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $2.38M trimmed.

  • Meiji Yasuda Asset Management's largest Q4 2021 buy was Neurocrine Biosciences: 6,430 shares worth $548K.
  • Meiji Yasuda Asset Management added most to Comcast in Q4 2021, an estimated $3.98M increase.
  • Meiji Yasuda Asset Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $2.38M.
  • Meiji Yasuda Asset Management fully exited News Corp Class A in Q4 2021, selling an estimated $1.2M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 23% of its $1.62B portfolio in Q4 2021.
  • Meiji Yasuda Asset Management opened 32 new positions and closed 11 in Q4 2021.
  • Meiji Yasuda Asset Management's portfolio value rose 15% quarter-over-quarter to $1.62B.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.